Trust Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Hold
4,335
0.02% 199
2026
Q1
$272K Hold
4,335
0.02% 193
2025
Q4
$288K Sell
4,335
-161
-4% -$10.4K 0.02% 185
2025
Q3
$303K Hold
4,496
0.02% 181
2025
Q2
$392K Hold
4,496
0.03% 158
2025
Q1
$307K Buy
4,496
+17
+0.4% +$1.39K 0.03% 171
2024
Q4
$348K Hold
4,479
0.03% 165
2024
Q3
$300K Hold
4,479
0.02% 180
2024
Q2
$508K Hold
4,479
0.04% 129
2024
Q1
$621K Hold
4,479
0.05% 116
2023
Q4
$556K Hold
4,479
0.05% 118
2023
Q3
$418K Hold
4,479
0.05% 132
2023
Q2
$576K Hold
4,479
0.06% 108
2023
Q1
$520K Buy
4,479
+57
+1% +$6.38K 0.06% 114
2022
Q4
$501K Hold
4,422
0.06% 114
2022
Q3
$356K Buy
4,422
+346
+8% +$29.3K 0.05% 139
2022
Q2
$304K Buy
4,076
+212
+5% +$19.3K 0.04% 147
2022
Q1
$494K Buy
3,864
+188
+5% +$20.6K 0.06% 112
2021
Q4
$493K Hold
3,676
0.06% 120
2021
Q3
$503K Buy
3,676
+252
+7% +$31.8K 0.07% 110
2021
Q2
$366K Buy
3,424
+364
+12% +$35K 0.05% 134
2021
Q1
$275K Buy
3,060
+552
+22% +$51.8K 0.04% 148
2020
Q4
$232K Buy
+2,508
New +$224K 0.04% 137

Other funds holding DXCM

Trust Asset Management's DXCM Position: Q2 2026 in Review

Trust Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 4,335 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #199.

Trust Asset Management first reported a position in DXCM in Q4 2020 and has held it in 23 quarters since. The position peaked at $621K in Q1 2024. 171 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Trust Asset Management held 4,335 shares of DexCom worth $292K as of Q2 2026.
  • Trust Asset Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.02% of Trust Asset Management's portfolio in Q2 2026, its #199 holding.
  • Trust Asset Management first reported a position in DexCom in Q4 2020 and has held it in 23 quarters since.
  • Trust Asset Management's DexCom position peaked at $621K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.